LabCorp ($LH) filed a Form 8‑K on Feb 17, 2026 reporting Item 2.02 — Results of Operations and Financial…
Filed with the SEC on · Summarized by InvestorsBot
LabCorp ($LH) filed a Form 8‑K on Feb 17, 2026 reporting Item 2.02 — Results of Operations and Financial Condition. Investors should review the full 8‑K/press release for revenue, EPS, cash flow and guidance impacts. 📄💡 #LabCorp #SECfiling
8‑K Item 2.02 often signals material quarter/period updates — check for changes to liquidity, debt covenants, and operating trends in LabCorp’s Feb 17, 2026 filing. Access the full document on SEC EDGAR for specifics. 🔍 $LH #Healthcare #investing
Note: the provided excerpt contains only the Item 2.02 header — no figures or management comments here. Do not trade on this summary; read the full 8‑K (Feb 17, 2026) for material amounts and disclosures. ⚖️ $LH #SEC #LabCorp